** = Publikationen gelistet in SCI/SSCI/Pubmed
** Byrne, NJ; Koentges, C; Khan, E; Pfeil, K; Sandulescu, R; Bakshi, S; Költgen, C; Vosko, I; Gollmer, J; Rathner, T; Rothf, G; Hoffmann, MM; Odening, KE; Orstmann, H; Potter, LA; Boded, C; Wolf, D; Sourij, H; Ljubojevic-Holzera, S; Wallnera, M; Rainer, PP; Sedej, S; Scherr, D; von Lewinski, D; Wende, AR; Zirlik, A; Bugger, H
Sirtuin 4 accelerates heart failure development by enhancing reactive oxygen species-mediated profibrotic transcriptional signaling
J MOL CELL CARD PLUS. 2025; 12: 100299
Doi: 10.1016/j.jmccpl.2025.100299
Web of Science
FullText
FullText_MUG
** Schwegel, N; Strohhofer, C; Kolesnik, E; Oltean, S; Hüttmair, A; Pipp, C; Benedikt, M; Verheyen, N; Gollmer, J; Ablasser, K; Wallner, M; Santner, V; Tripolt, N; Pferschy, P; Zechner, P; Alber, H; Siller-Matula, JM; Kopp, K; Zirlik, A; Aziz, F; Sourij, H; von, Lewinski, D
Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial.
Clin Res Cardiol. 2025; 114(5):629-639
Doi: 10.1007/s00392-024-02523-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwegel, N; Toferer, C; Zach, DK; Santner, V; Höller, V; Lugitsch, J; Wallner, M; Gollmer, J; Aziz, F; von, Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N
Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study.
J Clin Med. 2024; 13(19):
Doi: 10.3390/jcm13195966
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zach, DK; Schwegel, N; Santner, V; Winkelbauer, L; Hoeller, V; Kolesnik, E; Gollmer, J; Seggewiss, H; Batzner, A; Perl, S; Wallner, M; Reiter, U; Rainer, PP; Zirlik, A; Ablasser, K; Verheyen, N
Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
Int J Cardiol. 2024; 399:131661
Doi: 10.1016/j.ijcard.2023.131661
Web of Science
PubMed
FullText
FullText_MUG
** Gollmer, J; Zirlik, A; Bugger, H
Updated guidelines for cardiac patients with diabetes: Pragmatic diagnostic and therapeutic algorithm
DEUT MED WOCHENSCHR. 2024; 149(08): 470-475.
Doi: 10.1055/a-2226-0683
Web of Science
PubMed
FullText
FullText_MUG
** Toferer, C; Schwegel, N; Santner, ; Zach, DK; Hoeller, ; Wallner, M; Gollmer, J; Aziz, F; Von Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N
Prognostic impact of SGLT2-inhibitor therapy on survival in patients with transthyretin amyloid cardiomyopathy
EUR HEART J. 2024; 45(S1):ehae6662037--ESC Congress; AUG 30-SEP 02, 2024; London, UK.
Doi: 10.1093/eurheartj/ehae666.2037
[Poster]
Web of Science
FullText
FullText_MUG
** Winkelbauer, L; Santner, ; Schwegel, N; Hoeller, ; Gollmer, J; Kolesnik, E; Wallner, M; Von Lewinski, D; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Left atrial reservoir strain differentiates cardiac amyloidosis and hypertrophic cardiomyopathy
EUR HEART J. 2024; 45(S1):ehae666946--ESC Congress; AUG 30-SEP 02, 2024; London, UK.
Doi: 10.1093/eurheartj/ehae666.946
[Poster]
Web of Science
FullText
FullText_MUG
** von, Lewinski, D; Herold, L; Bachl, E; Bugger, H; Glantschnig, T; Kolesnik, E; Verheyen, N; Benedikt, M; Wallner, M; von, Lewinski, F; Schmidt, A; Harb, S; Ablasser, K; Sacherer, M; Scherr, D; Manninger-Wünscher, M; Pätzold, S; Gollmer, J; Zirlik, A; Toth, GG
Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort.
J Clin Med. 2023; 12(22):
Doi: 10.3390/jcm12226988
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gollmer, J; Zirlik, A
Identifying leukocyte phenotypes by scRNA-seq to predict cardiovascular risk.
Nat Rev Cardiol. 2023; 20(7):439-440
Doi: 10.1038/s41569-023-00891-1
Web of Science
PubMed
FullText
FullText_MUG
** Byrne, N; Koentges, C; Khan, E; Pfeil, K; Sandulescu, R; Bakshi, S; Koltgen, C; Vosko, I; Gollmer, J; Hoffmann, M; Wolf, D; Ljubojevic-Holzer, S; Wallner, M; Rainer, P; Sedej, S; Scherr, D; von Lewinski, D; Wende, A; Zirlik, A; Bugger, H
Sirtuin 4 accelerates heart failure development by enhancing reactive oxygen species-mediated profibrotic transcriptional signaling
WIEN KLIN WOCHENSCHR. 2023; 135: S398-S398.-Österreichische Kardiologische Gesellschaft (ÖKG); Salzburg, AUSTRIA.
[Poster]
Web of Science
** Gollmer, J; Horstmann, H; Potter, L; Vosko, I; Tomin, T; Pfeil, K; Briner-Gruenberger, R; Von Lewinski, D; Sedej, S; Scherr, D; Wende, AR; Rainer, P; Zirlik, A; Wolf, D; Bugger, H
Molecular alterations of human diabetic heart disease revealed using single nucleus RNA sequencing
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Lugitsch, J; Hoeller, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Lugitsch, J; Holler, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D
Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
WIEN KLIN WOCHENSCHR. 2023; 135: S472-S473.
[Poster]
Web of Science
FullText
** Strohhofer, C; Oltean, S; Huttmair, A; Pipp, C; Benedikt, M; Wallner, M; Verheyen, N; Gollmer, J; Ablasser, K; Hanfstingl-Sinz, D; Andorfer, J; Pachinger-Possl, S; Brunner, M; Rogozarski, J; Kolesnik, E
The SGLT2-inhibitor Empagliflozin improves Parameters of Diastolic Function after Myocardial Infarction measured by Echocardiography-a Single Center Sub Analysis of the EMMY-Trial
WIEN KLIN WOCHENSCHR. 2023; 135: S343-S345.
[Poster]
Web of Science
** Vosko, I; Holscher, ME; Koentges, C; Tarkhnishvili, A; Byrne, NJ; Pfeil, K; Tang, S; Gollmer, J; Hoffmann, MM; von Lewinski, D; Wallner, M; Bode, C; Zirlik, A; Bugger, H
SIRT4 deficiency modifies fatty acid utilization in the normal and diabetic heart
WIEN KLIN WOCHENSCHR. 2023; 135: S454-S454.
[Poster]
Web of Science
** Zach, D; Schwegel, N; Hoeller, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N
Comparing indices of systemic inflammation and cardiac phenotype between hypertensive and non-hypertensive hypertrophic cardiomyopathy
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS.
[Poster]
Web of Science
** Zach, D; Schwegel, N; Holler, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N
Comparing indices of systemic inflammation and cardiac phenotype in hypertensive and non-hypertensive hypertrophic cardiomyopathy
WIEN KLIN WOCHENSCHR. 2023; 135: S475-S476.
[Poster]
Web of Science
FullText
** Tarkhnishvili, A; Koentges, C; Pfeil, K; Gollmer, J; Byrne, NJ; Vosko, I; Lueg, J; Vogelbacher, L; Birkle, S; Tang, S; Bon-Nawul, Mwinyella, T; Hoffmann, MM; Odening, KE; Michel, NA; Wolf, D; Stachon, P; Hilgendorf, I; Wallner, M; Ljubojevic-Holzer, S; von, Lewinski, D; Rainer, P; Sedej, S; Sourij, H; Bode, C; Zirlik, A; Bugger, H
Effects of Short Term Adiponectin Receptor Agonism on Cardiac Function and Energetics in Diabetic db/db Mice.
J Lipid Atheroscler. 2022; 11(2):161-177
Doi: 10.12997/jla.2022.11.2.161
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Krall, M; Gollmer, J; Pollheimer, MJ; Reiter, C; Kolland, M; Kirsch, AH; Kronbichler, A; Eller, K; Rosenkranz, AR; Odler, B
Myocardial infarction with non-obstructive coronary arteries in a patient double-seropositive for anti-glomerular basement membrane and anti-neutrophil cytoplasmic antibodies: A case report.
Front Cardiovasc Med. 2022; 9: 893742
Doi: 10.3389/fcvm.2022.893742
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Byrne, NJ; Witt, CN; Koentges, C; Pfeil, K; Pusdrowski, T; Gollmer, J; Vosko, I; Bode, C; Zirlik, A; Bugger, H
SIRT5 is necessary for recovery from myocardial ischemia reperfusion injury
J MOL CELL CARDIOL. 2022; 173: S67-S67.Berlin, GERMANY.
Doi: 10.1016/j.yjmcc.2022.08.136
[Poster]
Web of Science
FullText
FullText_MUG
** Gollmer, J; Potter, L; Vosko, I; Tomin, T; Birner-Gruenberger, R; Von Lewinski, D; Sedej, S; Scherr, D; Wende, AR; Rainer, P; Zirlik, A; Bugger, H
Transcriptomic and proteomic profiling of human diabetic heart disease
EUR HEART J. 2022; 43: 2951-2951.
Web of Science
** Vosko, I; Gollmer, J; Hilvo, M; Jylha, A; Laaksonen, R; Marz, W; Zirlik, A; Bugger, H
Unsaturated ceramides as independent predictor for cardiovascular mortality in diabetic and non-diabetic subjects with coronary artery disease
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 2):173-173.
[Poster]
Web of Science
** Höller, V; Seebacher, H; Zach, D; Schwegel, N; Ablasser, K; Kolesnik, E; Gollmer, J; Waltl, G; Rainer, PP; Verheyen, S; Zirlik, A; Verheyen, N
Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy-The Graz Hypertrophic Cardiomyopathy Registry.
Genes (Basel). 2021; 12(10):
Doi: 10.3390/genes12101469
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tomin, T; Schittmayer, M; Sedej, S; Bugger, H; Gollmer, J; Honeder, S; Darnhofer, B; Liesinger, L; Zuckermann, A; Rainer, PP; Birner-Gruenberger, R
Mass Spectrometry-Based Redox and Protein Profiling of Failing Human Hearts.
Int J Mol Sci. 2021; 22(4):
Doi: 10.3390/ijms22041787
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tarkhnishvili, A; Gollmer, J; Koentges, C; Byrne, NJ; Pfeil, K; Mwinyella, TB; Wolf, D; Bode, C; Zirlik, A; Bugger, H
Effects of short term adiponectin receptor agonism on cardiac function and energetics in diabetic db/db mice
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 3):S49-S50.
[Oral Communication]
Web of Science
** Bugger, H; Gollmer, J; Pregartner, G; Wünsch, G; Berghold, A; Zirlik, A; von Lewinski, D
Complications and mortality of cardiovascular emergency admissions during COVID-19 associated restrictive measures.
PLoS One. 2020; 15(9):e0239801-e0239801
Doi: 10.1371/journal.pone.0239801
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gollmer, J; Zirlik, A; Bugger, H
Mitochondrial Mechanisms in Diabetic Cardiomyopathy.
Diabetes Metab J. 2020; 44(1):33-53
Doi: 10.4093/dmj.2019.0185
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Koentges, C; Khan, E; Birkle, S; Hoelscher, M; Pfeil, K; Gollmer, J; Hoffmann, MM; Bode, C; Zirlik, A; Bugger, H
Sirtuin 4 contributes to heart failure development by increasing mitochondrial oxidative stress.
EUR HEART J. 2020; 41: 3602-3602.
[Poster]
Web of Science
** Pepin, ME; Koentges, C; Pfeil, K; Gollmer, J; Kersting, S; Wiese, S; Hoffmann, MM; Odening, KE; von Zur Mühlen, C; Diehl, P; Stachon, P; Wolf, D; Wende, AR; Bode, C; Zirlik, A; Bugger, H
Dysregulation of the Mitochondrial Proteome Occurs in Mice Lacking Adiponectin Receptor 1.
Front Endocrinol (Lausanne). 2019; 10(1):872-872
Doi: 10.3389/fendo.2019.00872
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gollmer, J; Zirlik, A; Bugger, H
Established and Emerging Mechanisms of Diabetic Cardiomyopathy.
J Lipid Atheroscler. 2019; 8(1):26-47
Doi: 10.12997/jla.2019.8.1.26
[OPEN ACCESS]
PubMed
FullText
FullText_MUG